SomatoKine IGF-BP3 complex data

CTRX announced that three Phase I trials of recombinant insulin-like growth factor, complexed with its binding protein, shows safe delivery of IGF-I at higher doses

Read the full 251 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE